Knoll Capital Management
$179M 13F equity value
38 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Knoll Capital Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| MGTX | MeiraGTX Holdings | 1,250,000 | $17M | 9.4% |
| PHYS | Sprott physical gold Trust | 387,055 | $12M | 6.5% |
| ALDX | Aldeyra Therapeutics Inc | 5,475,516 | $12M | 6.5% |
| OCUL | Ocular Therapeutix Inc. | 1,150,400 | $11M | 6.3% |
| RGLD | Royal Gold Inc. | 52,750 | $11M | 5.9% |
| ENTX | Entera Bio Ltd | 5,881,879 | $10M | 5.8% |
| NUVB | Nuvation Bio Inc | 1,598,591 | $9M | 5.1% |
| AEM | Agnico Eagle Mines Ltd | 52,750 | $8M | 4.6% |
| SA | SEABRIDGE GOLD INC | 317,003 | $8M | 4.6% |
| KGC | Kinross Gold Corp | 320,000 | $8M | 4.2% |
Track Knoll Capital Management's 13F portfolio: $179M in reported holdings, 38 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}